Nanobiotix utilized Euronext for its global offering, with pricing based on the ECB published exchange rate.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nanobiotix utilized Euronext for its global offering, with pricing based on the ECB published exchange rate.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nanobiotix
French healthcare company
-
European Central Bank
central bank of the European Union and the eurozone
-
Euronext
pan-European bourse
Nothing else this week.
Related events
- Genus plc is anticipating the European Central Bank's upcoming interest rate decision.
- The European Central Bank is monitoring the crypto market, viewing it as a potential alternative.
- ECB rate hikes are affecting European markets, including exchanges in Italy and France.
- The European Central Bank announced a rate hike on September 10, 2026, originating from Berlin.